Investigating the therapeutic effects of paeoniflorin on atopic dermatitis and its potential pathogenesis through network pharmacology and in vivo and in vitro experiments
- 11 August 2025
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1005, 178057
Abstract
No abstract availableKeywords
Funding Information
- National Key Clinical Specialty Discipline Construction Program of China
This publication has 69 references indexed in Scilit:
- Advancements in pharmacological interventions for atopic dermatitis current strategies and future directionsInflammopharmacology, 2025
- Chinese Herbal Medicine and Their Active Ingredients Involved in the Treatment of Atopic Dermatitis Related Signaling PathwaysPhytotherapy Research, 2025
- Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic ReviewPharmacoEconomics, 2023
- The contribution of mouse models to understanding atopic dermatitisBiochemical Pharmacology, 2022
- Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic DermatitisAmerican Journal of Clinical Dermatology, 2022
- TLR4 polymorphisms as potential predictors of atopic dermatitis in Chinese Han childrenJournal of Clinical Laboratory Analysis, 2022
- The enhanced mitochondrial dysfunction by cantleyoside confines inflammatory response and promotes apoptosis of human HFLS-RA cell line via AMPK/Sirt 1/NF-κB pathway activationBiomedicine & Pharmacotherapy, 2022
- Exacerbating factors and disease burden in patients with atopic dermatitisAllergology International, 2022
- Subtypes of atopic dermatitis: From phenotype to endotypeAllergology International, 2022
- A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effectsBiomedicine & Pharmacotherapy, 2020